Treatment of Hypertension With Adalat® in Combination With Other Drugs

To investigate the therapeutic effectiveness of long acting nifedipine containing combination therapy in the treatment of hypertensive patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Many Locations, Bahrain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Previously untreated hypertensive patients starting with combination therapy containing nifedipine or
Insufficiently controlled hypertensive pts. receiving nifedipine as an add-on to existing non-CCB (calcium-channel-blocker) containing antihypertensive therapy

Exclusion criteria

None. Exclusion criteria are defined by contraindications and precautions as stated in the local product information.

Treatment and study plan

Nifedipine (Adalat, BAYA1040)

Drug

Previously untreated hypertensive adult patients starting with combination therapy containing nifedipine or insufficiently controlled hypertensive patients receiving nifedipine as an add-on to existing non-CCB containing antihypertensive therapy. The decision of including the patient as well as decision on dosage and duration is taken by the investigator.

Primary outcomes

Evaluation of treatment success (lowering of blood pressure in mmHg) in adult hypertensive patients

Time frame: After three months

Sponsors and collaborators

Lead sponsor

Bayer

Industry

Registry information

Official study title

AdADOSE - Antihypertensive Treatment With Adalat® in Different Doses and Combination Therapy

Important dates

Study start: 2010
Study completion: 2011
First posted: May 6, 2010
Registry last updated: Jun 27, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed